News Novartis AG

Equities

NOVN

CH0012005267

Market Closed - Swiss Exchange Other stock markets 11:30:46 2024-05-14 am EDT			5-day change	1st Jan Change
93.49 ^CHF	+0.45%		+4.13%	+10.16%

May. 13	Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales	DJ
May. 10	Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novartis receives FDA Breakthrough Therapy designation for Scemblix in 1L CML	May. 13	AQ
Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales	May. 13	DJ
Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation	May. 10	MT
Novartis Gets FDA Breakthrough Therapy Designation for Scemblix	May. 10	DJ
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update	May. 10	AQ
NOVARTIS AG : UBS maintains a Buy rating	May. 06	ZD
Health Care Flat Amid Mixed Earnings -- Health Care Roundup	May. 02	DJ
Sector Update: Health Care Stocks Softer Late Afternoon	May. 02	MT
Sector Update: Health Care Stocks Retreat Thursday Afternoon	May. 02	MT
Top Midday Stories: Novo Nordisk, Linde Shares Fall Post-Earnings; Peloton Shares Plummet After Announcing Job Cuts, CEO Change; Exxon-Pioneer Deal Gets FTC Approval With One Caveat	May. 02	MT
News Highlights : Top Company News of the Day - Thursday at 11 AM ET	May. 02	DJ
Novartis AG to Acquire Mariana Oncology in Deal Valued Up to $1.75 Billion.	May. 02	MT
News Highlights : Top Company News of the Day - Thursday at 9 AM ET	May. 02	DJ
Novartis : enters agreement to acquire Mariana Oncology, strengthening radioligand therapy pipeline	May. 02	PU
Novartis: acquisition of US-based Mariana Oncology	May. 02	CF
Switzerland's Novartis to Buy US-based Mariana Oncology for $1 Billion Upfront	May. 02	MT
Novartis to Buy Mariana Oncology, Pay $1 Billion Upfront	May. 02	MT
Novartis AG to Acquire Mariana Oncology	May. 02	MT
Novartis AG to Acquire Mariana Oncology	May. 02	MT
Novartis to Buy Mariana Oncology for Up to $1.75 Billion in Boost to Radioligand Therapy Business	May. 02	DJ